Brief: Helix Biopharma Q1 loss per share C$0.03
11/12/2015 22:42
Dec 11 (Reuters) - Helix Biopharma Corp HBP.TO : * Announces first quarter 2016 results * Q1 loss per share C$0.03 * Cash reserves of $5 million as at October 31 is insufficient to meet anticipated needs for working capital,capex through next 12 months * Source text for Eikon ID:nCCN3nYt6q * Further company coverage HBP.TO ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020